NRC Health
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Trent Green
- Full Time Employees
- 357
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 1245 Q Street Lincoln NE United States of America 68508
- IPO Date
- May 23, 2013
- CIK
- 0000070487
- Website
- nrchealth.com
- Similar Companies
- Business
- National Research Corporation (NRC) operates as a healthcare insights and analytics company specializing in healthcare experience management solutions designed to enhance patient, employee, physician, and consumer engagement. Its core offerings include multi-channel feedback collection and analysis platforms; patient and family experience measurement; resident and family experience programs for long-term care; employee and physician engagement solutions; healthcare analytics encompassing market and clinical outcomes analysis; health risk assessments; patient outreach initiatives; and integrated healthcare experience management solutions. NRC delivers these services primarily to healthcare providers, hospitals, and long-term care facilities across the United States with a strong emphasis on human-centered conversational listening enhanced by next-generation artificial intelligence technologies. Founded in 1981 and headquartered in Lincoln, Nebraska, NRC has recently focused on transformative growth by integrating advanced AI capabilities into its product suite to deliver more adaptive and personalized healthcare experience management tools. In 2024–2025, the company intensified investments in AI-enhanced healthcare-specific solutions set for market rollout, expanded its sales force, and pursued strategic initiatives to deepen customer engagement and market penetration. NRC also returned $18 million to shareholders through dividends and stock repurchases during the first quarter of 2024, signaling robust financial stewardship. The company's strategic roadmap includes leveraging AI and broadening its healthcare experience platform to better serve evolving client needs in a competitive market. NRC continues to reinforce its position as a leader in healthcare experience analytics by advancing innovative solutions that address regulatory compliance, patient satisfaction, and operational performance improvements. NRC operates exclusively in the healthcare industry with offerings tailored to hospitals, healthcare systems, long-term care providers, and related healthcare organizations across North America. The company maintains a comprehensive portfolio of market insights, consumer assessment programs (including CMS-approved surveys), clinical analytics, and consulting services. Its recent operational enhancements and AI focus position NRC at the forefront of delivering actionable data-driven insights that help healthcare organizations optimize patient outcomes, satisfaction, and loyalty while navigating regulatory and market pressures effectively.
Company News
Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?
NANO Nuclear's KRONOS MMR™ Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
NANO Nuclear's KRONOS MMR(TM) Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)
NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
New Momentum in the Nuclear Fuel Chain
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Mercy Earns National Honor for Excellence in Patient Experience
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
Financial Review: National Research (NASDAQ:NRC) versus Lynx Global Digital Finance (OTCMKTS:CNONF)
Terrestrial Energy Reports Second Quarter 2026 Results
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
NRC Health (NRC) Q2 2026 Earnings Call Transcript
National Research Q2 Earnings Call Highlights
NRC Health Announces Second Quarter 2026 Results
Nations Royalty Reports Fiscal 2026 Year-End Results and Provides Portfolio Update